News
06-07-2011, 02:11 AM
BioSante Pharmaceuticals, Inc. today announced that the FDA's clinical hold on the GVAX Prostate Cancer Vaccine for the treatment of prostate cancer has been lifted by FDA.
More... (http://www.news-medical.net/news/20110607/FDA-lifts-BioSantes-GVAX-Prostate-Cancer-Vaccine-clinical-hold.aspx)
More... (http://www.news-medical.net/news/20110607/FDA-lifts-BioSantes-GVAX-Prostate-Cancer-Vaccine-clinical-hold.aspx)